Literature DB >> 15943567

Seroprevalence and risk factors for human T cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus-infected patients attending AIDS referral center health units in Londrina and other communities in Paraná, Brazil.

Helena K Morimoto1, Adele Caterino-De-Araujo, Arilson A Morimoto, Edna M V Reiche, Luiz T Ueda, Tiemi Matsuo, Jan W Stegmann, Fernando V Reiche.   

Abstract

The municipality of Londrina ranks second in the number of AIDS cases in the state of Paraná, Brazil, with the Ministry of Health notified of 1070 cases from 1984 to 2002. The aim of this study was to determine the seroprevalence and risk factors for HTLV-1/2 infection in HIV-infected patients attending the AIDS Reference Center serving Londrina (and surrounding region), Paraná, Brazil. Data concerning sociodemographic conditions and risk factors were collected from 784 HIV-infected patients, using a questionnaire. Blood samples were obtained from 758 of the patients and subjected to serologic screening tests for the determination of HTLV-1/2, as well as hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis. Most patients were white (mean age, 35.9 years); 55.9% were males and 44.1% were females. The most frequent sexually transmitted disease was gonorrhea (28.5%), followed by syphilis (14.3%) and condyloma (12.2%). The major risk factors associated with the acquisition of retroviruses were sexual contact (84.8%) and intravenous drug use (IDU, 11.9%). The overall infection seroprevalence was 6.4% for HTLV-1/2, 37.2% for HBV, 21.0% for HCV, and 24.4% for syphilis. HTLV-1 and HTLV-2 infections were confirmed in 0.8 and 4.9% of patients, respectively. HIV/HTLV-1/2 coinfection was more frequent in IDUs (59.2% of cases) and was strongly associated with HCV (22.60 [95% CI, 10.35-49.35]). A weak association with HBV (2.09 [95% CI, 1.13-3.90]) and no association with syphilis were observed. The results showed that human retroviruses are circulating in southern Brazil, mainly among white people of both genders of low socioeconomic conditions and educational level. Although the sexual route was considered to be the major risk factor for HIV infection, HTLV-1/2 infection was strongly associated with IDU.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943567     DOI: 10.1089/aid.2005.21.256

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  15 in total

1.  Tax gene characterization of human T-lymphotropic virus type 1 strains from Brazilian HIV-coinfected patients.

Authors:  Mariana Cavalheiro Magri; Luis Fernando de Macedo Brigido; Rosangela Rodrigues; Helena Kaminami Morimoto; Adele Caterino-de-Araujo
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-20       Impact factor: 2.205

2.  The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus.

Authors:  Fabianna Bahia; Vinicius Novais; Jennifer Evans; Chloe Le Marchand; Eduardo Netto; Kimberly Page; Carlos Brites
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08       Impact factor: 3.731

3.  Phylogenetic and similarity analysis of HTLV-1 isolates from HIV-coinfected patients from the south and southeast regions of Brazil.

Authors:  Mariana Cavalheiro Magri; Luis Fernando de Macedo Brigido; Rosangela Rodrigues; Helena Kaminami Morimoto; João Leandro de Paula Ferreira; Adele Caterino-de-Araujo
Journal:  AIDS Res Hum Retroviruses       Date:  2011-06-24       Impact factor: 2.205

4.  Short Communication: Current Prevalence and Risk Factors Associated with Human T Lymphotropic Virus Type 1 and Human T Lymphotropic Virus Type 2 Infections Among HIV/AIDS Patients in São Paulo, Brazil.

Authors:  Adele Caterino-de-Araujo; Cláudio Tavares Sacchi; Maria Gisele Gonçalves; Karoline Rodrigues Campos; Mariana Cavalheiro Magri; Wong Kuen Alencar
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01-02       Impact factor: 2.205

5.  Human T cell lymphotropic virus type 2a strains among HIV type 1-coinfected patients from Brazil have originated mostly from Brazilian Amerindians.

Authors:  Mariana Cavalheiro Magri; Luis Fernando de Macedo Brigido; Helena Kaminami Morimoto; Adele Caterino-de-Araujo
Journal:  AIDS Res Hum Retroviruses       Date:  2013-04-11       Impact factor: 2.205

6.  Syphilis and HIV co-infection in patients who attend an AIDS outpatient clinic in Vitoria, Brazil.

Authors:  Fabiola Mesquita Callegari; Lauro Ferreira Pinto-Neto; Charlla Jezus Medeiros; Camila Binsi Scopel; Kimberly Page; Angélica Espinosa Miranda
Journal:  AIDS Behav       Date:  2014-01

Review 7.  HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status.

Authors:  Elisabetta Pilotti; Maria V Bianchi; Andrea De Maria; Federica Bozzano; Maria G Romanelli; Umberto Bertazzoni; Claudio Casoli
Journal:  Front Microbiol       Date:  2013-12-23       Impact factor: 5.640

8.  The first survey of human T-cell lymphotropic viruses (HTLV) in HIV/AIDS patients in Santa Catarina State, Brazil.

Authors:  Chaiana Esmeraldino Mendes Marcon; Karoline Rodrigues Campos; Gabriela Bassi da Silva; Fabiana Schuelter-Trevisol; Aline Daiane Schlindwein; Daisson José Trevisol; Adele Caterino-de-Araujo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-10-10       Impact factor: 1.846

9.  Line Immunoassay for Confirmation and Discrimination of Human T-Cell Lymphotropic Virus Infections in Inconclusive Western Blot Serum Samples from Brazil.

Authors:  Karoline R Campos; Fred L N Santos; Bernardo Galvão-Castro; Adele Caterino-de-Araujo; Vanessa da Silva Brito; Noilson L S Gonçalves; Thessika H A Araujo
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

10.  SEROPREVALENCE OF HTLV IN A POPULATION OF HIV1-INFECTED PATIENTS IN MIDWESTERN BRAZIL.

Authors:  Aline Garcia Kozlowski; Márcia Alves Dias de Matos; Megmar Aparecida Dos Santos Carneiro; Carmen Luci Rodrigues Lopes; Sheila Araújo Teles; Carolina Paulo Vicente; Regina Maria Bringel Martins
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-11-03       Impact factor: 1.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.